Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.23.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Nov. 18, 2022
Jul. 29, 2021
Dec. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jan. 29, 2021
Cash equivalents     $ 2,000 $ 2,000    
Gain loss on investment     $ 83,064    
Issuance of shares 1,000,000          
Issuance of value $ 1,000,000          
Share issued price per share $ 1.00   $ 0.28      
Salaries and wages     $ 49,837 145,472    
Fair value of investment cost     531,539      
Reverse stock split     1 for 3.763243      
Fair value of investment cost     $ 148,808      
Unrealized loss on securities     401,250      
Impairment expenses     195,000    
Investments     0      
Investment at fair value     18,812    
Marketable securities     $ 148,808      
Shares owned by fair value of investment     531,539      
Advertising, marketing and promotion expense     $ 1,740 4,331    
Property, plant and equipment, estimated useful lives     three to five years      
Depreciation expense     0    
Fair Value, Recurring [Member]            
Assets, Fair Value Disclosure     148,808 568,869    
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]            
Assets, Fair Value Disclosure     $ 148,808 $ 568,869 $ 148,808  
Convertible Notes Payable [Member]            
Antidilutive securities excluded from earnings per share amount     3,756,496 3,003,137    
Warrant [Member]            
Antidilutive securities excluded from earnings per share amount     0 740,000    
iGrow Systems Inc [Member]            
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners       43.15%    
Krypto Ventures Inc [Member]            
Issuance of shares   52,500,000        
Investment at fair value - related party     $ 0      
Descrypto Holdings Inc [Member]            
Issuance of shares   119,584,736        
Pharmacy No 27 Ltd [Member] | Descrypto [Member]            
Ownership percentage           20.00%
Pharmacy No Twenty Seven Ltd [Member]            
Unrealized loss on investments     $ 0      
WTechnologies Inc [Member]            
Issuance of shares   119,584,736        
Investment at fair value   $ 0        
Gain on deconsolidation   $ 153,907        
Related Party [Member]            
Equity method investment percentage, description     When the fair value of an investment is indeterminable, the Company accounts for its investments that are under 20% of the total equity outstanding using the cost method. For investments in which the Company holds between 20-50% equity and is non-controlling are accounted for using the equity method. For any investments in which the Company holds over 50% of the outstanding stock, the Company consolidates those entities into their condensed consolidated financial statements herein      
Each Anniversary [Member]            
Salaries and wages $ 500,000          
IPO [Member]            
Salaries and wages 200,000          
IPO [Member] | First Year [Member] | Monthly [Member]            
Salaries and wages 25,000          
IPO [Member] | Second Year [Member] | Monthly [Member]            
Salaries and wages $ 22,500          
EZFill Holdings, Inc, [Member]            
Received for shares     1,000,000